8 Stocks Rising on Monster Volume
Questcor Pharmaceuticals
Questcor Pharmaceuticals (QCOR) is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel, an injectable drug that is approved by the FDA. This stock is trading up 2.8% at $37.66 in recent trading.
Today's Volume: 2 million
Average Volume: 1.9 million Volume % Change: 84% From a technical standpoint, QCOR has started to find some buying interest recently near some previous support levels at around $33.66 to $34.15. Buyers have stepped into the stock near those levels and have pushed shares up to its current price of around $37.60. Market players should now watch for a breakout trade to trigger if QCOR can take out $38.34 and then its 50-day moving average of $40.30 on heavy volume. Look for volume on a move above those levels that registers near or above 1,933,260 shares. If we get that action soon, then this stock has a great chance to re-test $44.18 to $45.50 in the near future. Questcor was one of 5 Drug Stocks Winners of 2011.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
